PFM Health Sciences, LP
Clone Performance
Aug 2023–Aug 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. Returns use comparable raw closes and exclude dividends; a captured split can shorten the simulated window. It tracks 98% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
96 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Portfolio Trend
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,165,442,869 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| EPRX | Eupraxia Pharmaceuticals Inc. | +669,790 | 1,210,661 | $8,002,469 | |
| ICLR | Icon PLC | +78,982 | 136,482 | $23,708,288 | |
| KOD | Kodiak Sciences Inc. | +78,596 | 193,315 | $7,531,552 | |
| CNC | Centene Corp | +73,581 | 337,067 | $21,636,330 | |
| NVO | Novo Nordisk A S | +67,835 | 265,016 | $12,704,867 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | +67,388 | 131,667 | $10,732,177 | |
| ROIV | Roivant Sciences Ltd. | +60,562 | 268,008 | $9,484,803 | |
| ASND | Ascendis Pharma A/S | +58,737 | 233,171 | $62,191,369 | |
| COO | Cooper Companies, Inc. | +51,061 | 220,890 | $15,840,021 | |
| VERA | Vera Therapeutics, Inc. | +49,422 | 224,289 | $9,624,240 | |
| DFTX | Definium Therapeutics, Inc. | +43,703 | 249,020 | $11,713,900 | |
| SYK | Stryker Corp | +34,680 | 56,637 | $17,831,593 | |
| MMSI | Merit Medical Systems Inc | +34,569 | 197,038 | $13,662,614 | |
| UNH | Unitedhealth Group Inc | +30,238 | 88,276 | $36,690,153 | |
| WAT | Waters Corp /De/ | +20,062 | 59,825 | $22,436,768 | |
| OSCR | Oscar Health, Inc. | +19,179 | 519,016 | $14,802,336 | |
| CLDX | Celldex Therapeutics, Inc. | +17,794 | 342,751 | $12,753,764 | |
| ABVX | Abivax S.A. | +16,600 | 43,264 | $5,765,360 | |
| TMO | Thermo Fisher Scientific Inc. | +13,664 | 28,496 | $14,286,754 | |
| ILMN | Illumina, Inc. | +6,171 | 35,040 | $6,161,083 | |
| PRAX | Praxis Precision Medicines, Inc. | +3,137 | 38,575 | $12,914,524 | |
| INBX | Inhibrx Biosciences, Inc. | +2,954 | 308,385 | $29,219,478 | |
| RVMD | Revolution Medicines, Inc. | +2,452 | 143,222 | $26,822,616 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPS | COMPASS Pathways plc | −1,119,510 | 247,589 | $3,503,384 | |
| CRBU | Caribou Biosciences, Inc. | −603,100 | 354,687 | $624,249 | |
| AMRX | Amneal Pharmaceuticals, Inc. | −449,381 | 480,715 | $8,321,176 | |
| THC | Tenet Healthcare Corp | −271,995 | 126,572 | $23,679,089 | |
| INDV | Indivior Pharmaceuticals, Inc. | −173,458 | 401,208 | $16,461,564 | |
| SNDX | Syndax Pharmaceuticals Inc | −126,599 | 118,422 | $2,588,704 | |
| MLYS | Mineralys Therapeutics, Inc. | −80,259 | 62,418 | $1,684,037 | |
| TNGX | Tango Therapeutics, Inc. | −80,198 | 326,047 | $10,192,229 | |
| PEN | Penumbra Inc | −79,558 | 60,221 | $19,014,780 | |
| UTHR | UNITED THERAPEUTICS Corp | −67,414 | 49,991 | $27,086,623 | |
| ABT | Abbott Laboratories | −58,202 | 82,230 | $7,461,550 | |
| ACHC | Acadia Healthcare Company, Inc. | −57,811 | 524,934 | $15,501,301 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | −50,915 | 121,222 | $11,816,720 | |
| BTSG | BrightSpring Health Services, Inc. | −45,421 | 141,914 | $9,897,082 | |
| AXSM | Axsome Therapeutics, Inc. | −44,708 | 219,596 | $53,750,512 | |
| TARS | Tarsus Pharmaceuticals, Inc. | −39,647 | 40,579 | $2,554,042 | |
| NTRA | Natera, Inc. | −37,927 | 22,077 | $5,992,801 | |
| CGON | CG Oncology, Inc. | −37,639 | 128,286 | $9,114,720 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | −35,071 | 101,550 | $11,275,096 | |
| CGEM | Cullinan Therapeutics, Inc. | −34,964 | 192,442 | $3,504,368 | |
| GPCR | Structure Therapeutics Inc. | −34,833 | 91,550 | $4,913,488 | |
| LLY | ELI LILLY & Co | −26,504 | 39,258 | $47,087,226 | |
| BLTE | Belite Bio, Inc | −24,629 | 34,803 | $5,359,139 | |
| HSIC | Henry Schein Inc | −18,691 | 134,423 | $11,227,008 | |
| JAZZ | Jazz Pharmaceuticals plc | −17,376 | 160,768 | $38,740,264 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| HUM | Humana Inc | 94,375 | $37,487,637 | |
| MTD | Mettler Toledo International Inc/ | 13,344 | $17,047,093 | |
| MRK | Merck & Co., Inc. | 127,118 | $16,334,663 | |
| CYTK | Cytokinetics Inc | 191,686 | $16,329,730 | |
| LNTH | Lantheus Holdings, Inc. | 146,403 | $16,241,948 | |
| CVS | CVS HEALTH Corp | 137,457 | $14,219,926 | |
| GILD | Gilead Sciences, Inc. | 90,858 | $11,478,999 | |
| TFX | Teleflex Inc | 79,708 | $10,103,786 | |
| COR | Cencora, Inc. | 35,485 | $10,041,545 | |
| IRTC | iRhythm Holdings, Inc. | 65,196 | $7,755,064 | |
| WST | West Pharmaceutical Services Inc | 20,733 | $7,443,147 | |
| TAK | Takeda Pharmaceutical Co Ltd | 444,173 | $7,120,093 | |
| HNGE | Hinge Health, Inc. | 82,860 | $6,877,380 | |
| ARQT | Arcutis Biotherapeutics, Inc. | 242,069 | $6,347,049 | |
| IART | Integra Lifesciences Holdings Corp | 348,746 | $6,263,478 | |
| MGTX | MeiraGTx Holdings plc | 455,286 | $6,150,913 | |
| OCS | Oculis Holding AG | 436,042 | $6,047,902 | |
| GH | Guardant Health, Inc. | 36,701 | $5,506,251 | |
| CELC | Celcuity Inc. | 52,155 | $5,456,456 | |
| RCUS | Arcus Biosciences, Inc. | 152,129 | $4,690,137 | |
| CRL | Charles River Laboratories International, Inc. | 18,747 | $4,251,632 | |
| ELAN | Elanco Animal Health Inc | 172,489 | $4,244,954 | |
| BIO | Bio-Rad Laboratories, Inc. | 13,995 | $4,109,071 | |
| SYRE | Spyre Therapeutics, Inc. | 46,217 | $4,103,145 | |
| MIRM | Mirum Pharmaceuticals, Inc. | 31,536 | $3,691,919 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| GKOS | GLAUKOS Corp | 215,685 | $23,220,647 | |
| NEO | Neogenomics Inc | 1,784,552 | $13,241,375 | |
| DXCM | Dexcom Inc | 149,734 | $9,403,295 | |
| BLLN | BillionToOne, Inc. | 88,069 | $6,952,166 | |
| CAH | Cardinal Health Inc | 31,941 | $6,749,452 | |
| ALHC | Alignment Healthcare, Inc. | 359,826 | $6,340,134 | |
| PSNL | Personalis, Inc. | 870,097 | $5,542,517 | |
| MDLN | Medline Inc. | 86,777 | $3,861,576 | |
| GMED | Globus Medical Inc | 16,923 | $1,458,085 | |
| SLNO | Soleno Therapeutics Inc | 248,180 | $0 | |
| TERN | Terns Pharmaceuticals, Inc. | 172,962 | $0 | |
| CNTA | Centessa Pharmaceuticals plc | 528,224 | $0 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 233,171 | $62,191,369 | 5.34% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Reduced | 219,596 | $53,750,512 | 4.61% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 39,258 | $47,087,226 | 4.04% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
Reduced | 160,768 | $38,740,264 | 3.32% | |
| HUM |
Humana Inc
Healthcare
|
NEW | 94,375 | $37,487,637 | 3.22% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 88,276 | $36,690,153 | 3.15% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 213,407 | $35,967,615 | 3.09% | |
| INBX |
Inhibrx Biosciences, Inc.
Healthcare
|
Added | 308,385 | $29,219,478 | 2.51% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Reduced | 49,991 | $27,086,623 | 2.32% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 143,222 | $26,822,616 | 2.30% | |
| ICLR |
Icon PLC
Healthcare
|
Added | 136,482 | $23,708,288 | 2.03% | |
| THC |
Tenet Healthcare Corp
Healthcare
|
Reduced | 126,572 | $23,679,089 | 2.03% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Reduced | 250,453 | $22,655,978 | 1.94% | |
| WAT |
Waters Corp /De/
Healthcare
|
Added | 59,825 | $22,436,768 | 1.93% | |
| CNC |
Centene Corp
PUT
+ SHARES
Healthcare
|
Added | 337,067 | $21,636,330 | 1.86% | |
| PEN |
Penumbra Inc
Healthcare
|
Reduced | 60,221 | $19,014,780 | 1.63% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 253,358 | $18,870,103 | 1.62% | |
| SYK |
Stryker Corp
Healthcare
|
Added | 56,637 | $17,831,593 | 1.53% | |
| MTD |
Mettler Toledo International Inc/
Healthcare
|
NEW | 13,344 | $17,047,093 | 1.46% | |
| INDV |
Indivior Pharmaceuticals, Inc.
Healthcare
|
Reduced | 401,208 | $16,461,564 | 1.41% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
NEW | 127,118 | $16,334,663 | 1.40% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 191,686 | $16,329,730 | 1.40% | |
| LNTH |
Lantheus Holdings, Inc.
Healthcare
|
NEW | 146,403 | $16,241,948 | 1.39% | |
| COO |
Cooper Companies, Inc.
Healthcare
|
Added | 220,890 | $15,840,021 | 1.36% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Reduced | 29,313 | $15,739,615 | 1.35% | |
| ACHC |
Acadia Healthcare Company, Inc.
Healthcare
|
Reduced | 524,934 | $15,501,301 | 1.33% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Reduced | 158,825 | $15,115,375 | 1.30% | |
| OSCR |
Oscar Health, Inc.
Healthcare
|
Added | 519,016 | $14,802,336 | 1.27% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Added | 28,496 | $14,286,754 | 1.23% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
NEW | 137,457 | $14,219,926 | 1.22% | |
| MMSI |
Merit Medical Systems Inc
Healthcare
|
Added | 197,038 | $13,662,614 | 1.17% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 38,575 | $12,914,524 | 1.11% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Added | 342,751 | $12,753,764 | 1.09% | |
| NVO |
Novo Nordisk A S
Healthcare
|
Added | 265,016 | $12,704,867 | 1.09% | |
| ITGR |
Integer Holdings Corp
Healthcare
|
Reduced | 126,669 | $11,837,218 | 1.02% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 121,222 | $11,816,720 | 1.01% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
Added | 249,020 | $11,713,900 | 1.01% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
NEW | 90,858 | $11,478,999 | 0.98% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Reduced | 101,550 | $11,275,096 | 0.97% | |
| HSIC |
Henry Schein Inc
Healthcare
|
Reduced | 134,423 | $11,227,008 | 0.96% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Added | 131,667 | $10,732,177 | 0.92% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Reduced | 326,047 | $10,192,229 | 0.87% | |
| TFX |
Teleflex Inc
Healthcare
|
NEW | 79,708 | $10,103,786 | 0.87% | |
| COR |
Cencora, Inc.
CALL
+ SHARES
Healthcare
|
NEW | 35,485 | $10,041,545 | 0.86% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
Reduced | 255,330 | $9,960,423 | 0.85% | |
| BTSG |
BrightSpring Health Services, Inc.
Healthcare
|
Reduced | 141,914 | $9,897,082 | 0.85% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Added | 224,289 | $9,624,240 | 0.83% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Added | 268,008 | $9,484,803 | 0.81% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Reduced | 128,286 | $9,114,720 | 0.78% | |
| AMRX |
Amneal Pharmaceuticals, Inc.
Healthcare
|
Reduced | 480,715 | $8,321,176 | 0.71% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.